Location History:
- Greenwold, IN (US) (1996)
- Greenwood, IN (US) (1980 - 2002)
Company Filing History:
21 out of 4,446 
1 out of 35 
1 out of 832,843 Years Active: 1980-2002
Title: The Innovator's Journey of Celia A. Whitesitt
Introduction
Celia A. Whitesitt, based in Greenwood, Indiana, has made significant contributions to the field of pharmaceuticals through her innovative inventions. With an impressive portfolio of 23 patents, she has dedicated her career to developing solutions for serious health conditions, particularly Alzheimer's disease.
Latest Patents
Celia's recent patents reflect her commitment to advancing medical science. One noteworthy patent involves N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions comprising these compounds, and methods for inhibiting alpha-amyloid peptide release and/or its synthesis. These inventions showcase her ability to design compounds that can inhibit beta-amyloid peptide release, demonstrating potential in treating Alzheimer’s disease. Additionally, she has developed benzylidene rhodanines, which are useful agents in treating or preventing conditions associated with beta-amyloid peptide, further contributing to the fight against Alzheimer's disease through effective therapeutic methods.
Career Highlights
Throughout her career, Celia has worked with notable companies such as Eli Lilly and Company, where she honed her expertise in the pharmaceutical industry, and Athena Neurosciences, Inc., where she continued her focus on neurological diseases. Her depth of knowledge and innovation has solidified her reputation as a leading inventor in her field.
Collaborations
Celia A. Whitesitt has collaborated with distinguished colleagues, including Jon Kevin Reel and Richard L. Simon. These partnerships have fostered groundbreaking research and the successful development of her patents, enhancing the potential to offer new treatments for Alzheimer’s disease.
Conclusion
Celia A. Whitesitt's contributions to the field of pharmaceuticals and her relentless pursuit of innovation echo through her numerous patents. Her work not only represents a significant advancement in the treatment of Alzheimer's disease but also inspires future generations of inventors and researchers in the medical field. Her journey showcases the powerful impact that dedicated inventors can have on society through their innovative solutions.